These are the 5 scientists and executives getting the richest off Moderna's spike to record highs | Markets Insider

Deutschland Nachrichten Nachrichten

These are the 5 scientists and executives getting the richest off Moderna's spike to record highs | Markets Insider
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

These are the 5 scientists and executives getting the richest off Moderna's spike to record highs

stock soared to record highs on Monday, minting new fortunes for a small group of executives and scientists.on Monday after it revealed its coronavirus vaccine's phase-one results. The experimental drug successfully produced antibodies in all 45 volunteers, Moderna said. The company plans to begin phase-three trials in July and to roll out a vaccine for emergency use in the fall.

The positive results lifted the market as well, with the S&P 500 leaping as much as 3.4% in Monday trading. "We could not be happier with this interim data," CEO Stephane Bancel said in a Monday call with analysts. Some analysts think the stock still has room to run as its critical vaccine moves further into trials.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

BusinessInsider /  🏆 729. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Moderna Reveals ‘Positive’ Data In Coronavirus Vaccine Trial, Markets SpikeModerna Reveals ‘Positive’ Data In Coronavirus Vaccine Trial, Markets SpikeBoston biopharmaceutical Moderna announced today that “positive” data was collected from an early-stage human trial of a coronavirus vaccine by lisettevoytko
Weiterlesen »

Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says | Markets InsiderModerna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says | Markets InsiderGoldman Sachs lifted its price target for Moderna stock to $105 from $63 on Monday after first trials for its coronavirus drug showed 'encouragi...
Weiterlesen »

Stocks making the biggest moves midday: Moderna, Delta, Bank of America, Best Buy, Disney & moreStocks making the biggest moves midday: Moderna, Delta, Bank of America, Best Buy, Disney & moreModerna shares spike on 'positive data' from its coronavirus vaccine trial. Netflix shares slip as investors rotate out of 'stay-at-home' stocks.
Weiterlesen »

Stéphane Bancel, CEO of Moderna, the biotech making a COVID-19 vaccine - Business InsiderStéphane Bancel, CEO of Moderna, the biotech making a COVID-19 vaccine - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »

Coronavirus tsar to divest his $10 million in stocks from Moderna - Business InsiderCoronavirus tsar to divest his $10 million in stocks from Moderna - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »

Moderna coronavirus vaccine releases first human trial results - Business InsiderModerna coronavirus vaccine releases first human trial results - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »



Render Time: 2025-03-31 04:38:25